Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis

Regulatory Toxicology and Pharmacology : RTP
Lesa L AylwardSean M Hays

Abstract

In chemical risk assessment, exposures in humans are often compared to no-observed-adverse-effect levels or benchmark doses for sensitive adverse responses ("points of departure") in laboratory species to assess whether a sufficient "margin of exposure" (MOE) is attained to ensure safety. Conventionally, the default target MOE based on external dose is drawn from uncertainty factors of 10 each for inter- and intra-species extrapolation. The increasing availability of blood-based biomonitoring data in humans as well as measured and modeled blood concentrations in laboratory animals in key studies underlying chemical risk assessments may allow assessments of MOE to be made by comparing blood concentrations of parent compound in humans compared to those in the laboratory species at the point of departure for the risk assessment. This exploratory analysis provides an initial evaluation of whether the default MOE of 100 typically applied on an external dose basis is protective when applied on the basis of comparison of blood concentrations between laboratory animals and humans. The evaluation is conducted using a generic physiologically-based pharmacokinetic model of the structure typically applied to volatile organic compounds. Add...Continue Reading

References

Sep 1, 1983·Regulatory Toxicology and Pharmacology : RTP·M L Dourson, J F Stara
Jun 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·R TardifK Krishnan
Oct 1, 1996·Regulatory Toxicology and Pharmacology : RTP·M L DoursonD Robinson
Jul 1, 1997·Toxicology and Industrial Health·R P BrownR P Beliles
Jun 10, 1998·Regulatory Toxicology and Pharmacology : RTP·A G Renwick, N R Lazarus
Dec 12, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·K WaltonA G Renwick
Dec 12, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Jul 26, 2005·Toxicology and Applied Pharmacology·Shakil A SaghirJames S Bus
Jul 13, 2006·Risk Analysis : an Official Publication of the Society for Risk Analysis·Weihsueh A Chiu, Paul White
Jun 28, 2008·Regulatory Toxicology and Pharmacology : RTP·Sean M HaysUNKNOWN Biomonitoring Equivalents Expert Workshop
Sep 16, 2009·Regulatory Toxicology and Pharmacology : RTP·Lesa L AylwardKannan Krishnan
Dec 29, 2009·Toxicology and Applied Pharmacology·Clark D Carrington, P Michael Bolger

❮ Previous
Next ❯

Citations

Feb 25, 2015·Regulatory Toxicology and Pharmacology : RTP·Grace PatlewiczRichard A Becker
Apr 21, 2012·Journal of Toxicology·Richard A BeckerLesa L Aylward
Dec 3, 2014·Environment International·Jan L LycheAnuschka Polder
Jan 7, 2014·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Richard A BeckerKimberly Wise
Nov 10, 2015·Journal of Occupational and Environmental Hygiene·Eileen D KuempelAnnie M Jarabek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.